|Podcasts|July 8, 2022
Addressing Rising Rx Costs
Author(s)Nicholas Saraceno, Editor, Julian Upton
How did the industry get here and what alternatives can be sought out?
Advertisement
Nelly Rose, PharmD, VP of clinical consulting for NFP, an insurance broker and consultant that provides solutions to clients that span numerous industries, addresses the increase in prescription drug spending, along with ways to find more affordable options for driving down pharmacy spend, including the impact of biosimilars in the marketplace.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novartis’ $23 Billion Manufacturing Investment Anchors Industry Shift Toward US Onshoring
2
CEVA Logistics Expands End-to-End Capabilities With Acquisition of Project Logistics Specialist Fagioli
3
Trade & Channel Strategies 2025: Why Product-Level Strategy Matters More Than Ever
4
Pharma Pulse: The ACA Subsidy Cliff and New Frontiers for GLP-1s
5